Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects
NCT04958187
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemodialysis
Interventions
DRUG:
ANG-3777
Sponsor
Angion Biomedica Corp
Collaborators
[object Object]